Off-label drug use in pediatric patients

Clinical Pharmacology and Therapeutics

Volumn 91, Issue 5, 2012, Pages 796-801

  Kimland, E ^a   Odlind, V ^a  

^a MEDICAL PRODUCTS AGENCY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANALGESIC AGENT; ANTIBIOTIC AGENT; CARBOHYDRATE; CARDIOVASCULAR AGENT; DICLOFENAC; ELECTROLYTE; GLUCOSAMINE; IMMUNOSUPPRESSIVE AGENT; MORPHINE; PARACETAMOL;

ADVERSE OUTCOME; BODY SURFACE; BODY WEIGHT; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG ELIMINATION; DRUG LABELING; DRUG METABOLISM; DRUG SURVEILLANCE PROGRAM; DRUG UTILIZATION; ELECTROLYTE INTAKE; GLUCOSE INFUSION; GOVERNMENT REGULATION; HUMAN; INFORMATION DISSEMINATION; KIDNEY FUNCTION; LIVER FUNCTION; NEWBORN CARE; NEWBORN INTENSIVE CARE; OFF LABEL DRUG USE; PEDIATRIC WARD; PEDIATRICS; PRIORITY JOURNAL; REVIEW; TOPICAL TREATMENT;

CHILD; DRUG TOXICITY; HUMANS; OFF-LABEL USE; PEDIATRICS; RISK;

EID: 84859930662     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2012.26     Document Type: Review

References (63)

1. Kearns, G.L., Abdel-Rahman, S.M., Alander, S.W., Blowey, D.L., Leeder, J.S. & Kauffman, R.E. Developmental pharmacology-drug disposition, action, and therapy in infants and children. N. Engl. J. Med. 349, 1157-1167 (2003).
2. Rane, A. Drug metabolism and disposition in infants and children. In: Neonatal and Pediatric Pharmacology: Therapeutic Principles in Practice, 3rd edn., Vol. (ed. Y affe SJ & Aranda, J.V.) 32-43 (Saunders, Philadelphia, PA, 2005).
3. Johnson, T.N. The problems in scaling adult drug doses to children. Arch. Dis. Child. 93, 207-211 (2008).
4. Mahmood, I. Prediction of drug clearance in children from adults: a comparison of several allometric methods. Br. J. Clin. Pharmacol. 61, 545-557 (2006).
5. Sanz, E.J., Bergman, U. & Dahlström, M. Paediatric drug prescribing. A comparison of Tenerife (Canary Islands, Spain) and Sweden. Eur. J. Clin. Pharmacol. 37, 65-68 (1989).
6. Clavenna, A. & Bonati, M. Drug prescriptions to outpatient children: a review of the literature. Eur. J. Clin. Pharmacol. 65, 749-755 (2009).
7. Neubert, A. et al. Databases for pediatric medicine research in Europe- assessment and critical appraisal. Pharmacoepidemiol. Drug Saf. 17, 1155-1167 (2008).
8. Wong, I.C., Basra, N., Yeung, V.W. & Cope, J. Supply problems of unlicensed and off-label medicines after discharge. Arch. Dis. Child. 91, 686-688 (2006).
9. Olsson, J., Kimland, E., Pettersson, S. & Odlind, V. Paediatric drug use with focus on off-label prescriptions in Swedish outpatient care-a nationwide study. Acta Paediatr. 100, 1272-1275 (2011).
10. Spigelblatt, L., Laîné-Ammara, G., Pless, I.B. & Guyver, A. The use of alternative medicine by children. Pediatrics 94, 811-814 (1994).
11. Lanski, S.L., Greenwald, M., Perkins, A. & Simon, H.K. Herbal therapy use in a pediatric emergency department population: expect the unexpected. Pediatrics 111, 981-985 (2003).
12. Pitetti, R., Singh, S., Hornyak, D., Garcia, S.E. & Herr, S. Complementary and alternative medicine use in children. Pediatr. Emerg. Care 17, 165-169 (2001).
13. Noonan, K., Arensman, R.M. & Hoover, J.D. Herbal medication use in the pediatric surgical patient. J. Pediatr. Surg. 39, 500-503 (2004).
14. Jean, D. & Cyr, C. Use of complementary and alternative medicine in a general pediatric clinic. Pediatrics 120, e138-e141 (2007).
15. Major, S. et al. Drug-related hospitalization at a tertiary teaching center in Lebanon: incidence, associations, and relation to self-medicating behavior. Clin. Pharmacol. Ther. 64, 450-461 (1998).
16. Nydert, P., Kimland, E., Kull, I. & Lindemalm, S. Over-the-counter drug use-estimations within the Swedish paediatric population. Eur. J. Pediatr. 170, 583-588 (2011).
17. Menniti-Ippolito, F. et al. Surveillance of suspected adverse reactions to natural health products in Italy. Pharmacoepidemiol. Drug Saf. 17, 626-635 (2008).
18. Di Paolo, E.R. et al. Unlicensed and off-label drug use in a Swiss paediatric university hospital. Swiss Med. Wkly. 136, 218-222 (2006).
19. Turner, S., Gill, A., Nunn, T., Hewitt, B. & Choonara, I. Use of "off-label" and unlicensed drugs in paediatric intensive care unit. Lancet 347, 549-550 (1996).
20. Turner, S., Longworth, A., Nunn, A.J. & Choonara, I. Unlicensed and off label drug use in paediatric wards: prospective study. BMJ 316, 343-345 (1998).
21. Conroy, S. et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children. BMJ 320, 79-82 (2000).
22. Gavrilov, V., Lifshitz, M., Levy, J. & Gorodischer, R. Unlicensed and off-label medication use in a general pediatrics ambulatory hospital unit in Israel. Isr. Med. Assoc. J. 2, 595-597 (2000).
23. Craig, J.S., Henderson, C.R. & Magee, F.A. The extent of unlicensed and off-label drug use in the paediatric ward of a district general hospital in Northern Ireland. Ir. Med. J. 94, 237-240 (2001).
24. 't Jong, G.W., Vulto, A.G., de Hoog, M., Schimmel, K.J., Tibboel, D. & van den Anker, J.N. A survey of the use of off-label and unlicensed drugs in a Dutch children's hospital. Pediatrics 108, 1089-1093 (2001).
25. 'T Jong, G.W., Eland, I.A., Sturkenboom, M.C., van den Anker, J.N. & Stricker, B.H. Unlicensed and off label prescription of drugs to children: population based cohort study. BMJ 324, 1313-1314 (2002).
26. Pandolfini, C., Impicciatore, P., Provasi, D., Rocchi, F., Campi, R. & Bonati, M. Off-label use of drugs in Italy: a prospective, observational and multicentre study. Acta Paediatr. 91, 339-347 (2002).
27. Schirm, E., Tobi, H. & de Jong-van den Berg, L.T. Unlicensed and off label drug use by children in the community: cross sectional study. BMJ 324, 1312-1313 (2002).
28. Morales-Carpi, C., Estañ, L., Rubio, E., Lurbe, E. & Morales-Olivas, F.J. Drug utilization and off-label drug use among Spanish emergency room paediatric patients. Eur. J. Clin. Pharmacol. 66, 315-320 (2010).
29. Kimland, E., Nydert, P., Odlind, V., Böttiger, Y. & Lindemalm, S. Paediatric drug use with focus on off-label prescriptions at Swedish hospitals-a nationwide study. Acta Paediatr.; e-pub ahead of print 8 March 2012.
30. Ufer, M., Rane, A., Karlsson, A., Kimland, E. & Bergman, U. Widespread off-label prescribing of topical but not systemic drugs for 350,000 paediatric outpatients in Stockholm. Eur. J. Clin. Pharmacol. 58, 779-783 (2003).
31. Brion, F., Nunn, A.J. & Rieutord, A. Extemporaneous (magistral) preparation of oral medicines for children in European hospitals. Acta Paediatr. 92, 486-490 (2003).
32. Nahata, M.C. & Allen, L.V. Jr. Extemporaneous drug formulations. Clin. Ther. 30, 2112-2119 (2008).
33. 't Jong, G.W.et al. Unlicensed and off-label drug use in a paediatric ward of a general hospital in the Netherlands. Eur. J. Clin. Pharmacol. 58, 293-297 (2002).
34. Lass, J., Käär, R., Jõgi, K., Varendi, H., Metsvaht, T. & Lutsar, I. Drug utilisation pattern and off-label use of medicines in Estonian neonatal units. Eur. J. Clin. Pharmacol. 67, 1263-1271 (2011).
35. O'Donnell, C.P., Stone, R.J. & Morley, C.J. Unlicensed and off-label drug use in an Australian neonatal intensive care unit. Pediatrics 110, e52 (2002).
36. Lindell-Osuagwu, L., Korhonen, M.J., Saano, S., Helin-Tanninen, M., Naaranlahti, T. & Kokki, H. Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature. J. Clin. Pharm. Ther. 34, 277-287 (2009).
37. Conroy, S., McIntyre, J. & Choonara, I. Unlicensed and off label drug use in neonates. Arch. Dis. Child. Fetal Neonatal Ed. 80, F142-F145 (1999).
38. Chalumeau, M. et al. Off label and unlicensed drug use among French office based paediatricians. Arch. Dis. Child. 83, 502-505 (2000).
39. McIntyre, J., Conroy, S., Avery, A., Corns, H. & Choonara, I. Unlicensed and off label prescribing of drugs in general practice. Arch. Dis. Child. 83, 498-501 (2000).
40. Bücheler, R. et al. Off label prescribing to children in primary care in Germany: retrospective cohort study. BMJ 324, 1311-1312 (2002).
41. Lass, J., Irs, A., Pisarev, H., Leinemann, T. & Lutsar, I. Off label use of prescription medicines in children in outpatient setting in Estonia is common. Pharmacoepidemiol. Drug Saf. 20, 474-481 (2011).
42. Schirm, E., Tobi, H., de Vries, T.W., Choonara, I. & De Jong-van den Berg, L.T. Lack of appropriate formulations of medicines for children in the community. Acta Paediatr. 92, 1486-1489 (2003).
43. Ekins-Daukes, S., Helms, P.J., Taylor, M.W. & McLay, J.S. Off-label prescribing to children: attitudes and experience of general practitioners. Br. J. Clin. Pharmacol. 60, 145-149 (2005).
44. Mukattash, T., Hawwa, A.F., Trew, K. & McElnay, J.C. Healthcare professional experiences and attitudes on unlicensed/off-label paediatric prescribing and paediatric clinical trials. Eur. J. Clin. Pharmacol. 67, 449-461 (2011).
45. Turner, S., Nunn, A.J., Fielding, K. & Choonara, I. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paediatr. 88, 965-968 (1999).
46. Horen, B., Montastruc, J.L. & Lapeyre-Mestre, M. Adverse drug reactions and off-label drug use in paediatric outpatients. Br. J. Clin. Pharmacol. 54, 665-670 (2002).
47. Jonville-Béra, A.P., Béra, F. & Autret-Leca, E. Are incorrectly used drugs more frequently involved in adverse drug reactions? A prospective study. Eur. J. Clin. Pharmacol. 61, 231-236 (2005).
48. Ufer, M., Kimland, E. & Bergman, U. Adverse drug reactions and off-label prescribing for paediatric outpatients: a one-year survey of spontaneous reports in Sweden. Pharmacoepidemiol. Drug Saf. 13, 147-152 (2004).
49. Aagaard, L. & Hansen, E.H. Prescribing of medicines in the Danish paediatric population outwith the licensed age group: characteristics of adverse drug reactions. Br. J. Clin. Pharmacol. 71, 751-757 (2011).
50. Kimland, E., Rane, A., Ufer, M. & Panagiotidis, G. Paediatric adverse drug reactions reported in Sweden from 1987 to 2001. Pharmacoepidemiol. Drug Saf. 14, 493-499 (2005).
51. Spray, A. & Siegfried, E. Dermatologic toxicology in children. Pediatr. Ann. 30, 197-202 (2001).
52. Alvarez-Requejo, A., Carvajal, A., Bégaud, B., Moride, Y., Vega, T. & Arias, L.H. Under-reporting of adverse drug reactions. Estimate based on a spontaneous reporting scheme and a sentinel system. Eur. J. Clin. Pharmacol. 54, 483-488 (1998).
53. Bäckström, M., Mjörndal, T. & Dahlqvist, R. Under-reporting of serious adverse drug reactions in Sweden. Pharmacoepidemiol. Drug Saf. 13, 483-487 (2004).
54. European Medicines Agency. Medicines for children 〈http://www.ema. europa.eu/ema/index.jsp?curl=pages/regulation/document-listing/ document-listing-000068.jsp&mid=WC0b01ac0580025b8b〉.
55. Choonara, I. & Conroy, S. Unlicensed and off-label drug use in children: implications for safety. Drug Saf. 25, 1-5 (2002).
56. Kimland, E., Böttiger, Y. & Lindemalm, S. Recent drug history in children visiting a pediatric emergency room and documentation in medical records. Eur. J. Clin. Pharmacol. 67, 1085-1089 (2011).
57. Conroy, S. & Peden, V. Unlicensed and off label analgesic use in paediatric pain management. Paediatr. Anaesth. 11, 431-436 (2001).
58. Medicines for children, Priority list of off-patent medicines. European Medicines Agency (EMA) 〈http://www.ema.europa.eu/ema/index. jsp?curl=pages/regulation/document-listing/document-listing-000092. jsp&mid=WC0b01ac05800260a4〉.
59. Pasquali, S.K. et al. Off-label use of cardiovascular medications in children hospitalized with congenital and acquired heart disease. Circ. Cardiovasc. Qual. Outcomes 1, 74-83 (2008).
60. Bajcetic, M. et al. Off label and unlicensed drugs use in paediatric cardiology. Eur. J. Clin. Pharmacol. 61, 775-779 (2005).
61. Santos, D.B., Clavenna, A., Bonati, M. & Coelho, H.L. Off-label and unlicensed drug utilization in hospitalized children in Fortaleza, Brazil. Eur. J. Clin. Pharmacol. 64, 1111-1118 (2008).
62. Barr, J. et al. Unlicensed and off-label medication use in a neonatal intensive care unit: a prospective study. Am. J. Perinatol. 19, 67-72 (2002).
63. Dell'Aera, M. et al. Unlicensed and off-label use of medicines at a neonatology clinic in Italy. Pharm. World Sci. 29, 361-367 (2007).